Trials / Completed
CompletedNCT03740074
Personal Activity Intelligence (PAI) Pilot
Evaluation of Personal Activity Intelligence (PAI) Score Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Ohio University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pilot study to evaluate the use of the Personal Activity Intelligence (PAI) score in a clinical setting.
Detailed description
This is a pilot project to evaluate the feasibility of a larger study to evaluate the effectiveness of Personal Activity Intelligence (PAI) score in patients with chronic disease, as an adjunct to lifestyle medical therapy. The PAI score is a proprietary formula developed by PAI Health (PH) to aid physical fitness. A PAI score calculation uses biometrics obtained via a device that measures heart rate and steps. For this study, Mio Slice, a commercial wrist worn device will be utilized to obtain data which will be linked to a smart phone. Data from the smart phone app will be accessed by PAI Health. Feedback information will be given to the participants to encourage increased physical activity. The short-term aim of this study is to evaluate the logistics of utilizing PAI in the patient setting. The data obtained from this study will be utilized to devise a larger study to evaluate the utility of PAI in patients with chronic disease who are receiving lifestyle medical therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | PAI | Consenting subjects will be given a Mio Slice, along with instructions on how to utilize the device. They will register on line with PAI Health, and will be asked to sync their device at least once every 7 days. They will be encouraged to look at the device app on their smart phone at least once daily. After 1 week of obtaining baseline data, subjects will be encouraged to try to obtain a PAI score of at least 30 initially. Once they obtain a score of 30 consistently, they will be encouraged to increase the score toward 50. If they consistently obtain 50, they can increase their goal sequentially toward a maximum goal of 100. The duration of the study will be 12 weeks. |
Timeline
- Start date
- 2018-10-02
- Primary completion
- 2019-06-30
- Completion
- 2019-12-31
- First posted
- 2018-11-14
- Last updated
- 2020-09-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03740074. Inclusion in this directory is not an endorsement.